18.11.2014 Views

Annual report 2006 - Dexia.com

Annual report 2006 - Dexia.com

Annual report 2006 - Dexia.com

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

RAPPORT DE GESTION<br />

CONSOLIDATED<br />

FINANCIAL STATEMENTS<br />

COMPTES SOCIAUX<br />

Shadow loss adjustment<br />

To determine the need for a shadow loss adjustment <strong>Dexia</strong><br />

determines if additional liabilities would be required, assuming<br />

current market investment yields rather than the estimated<br />

return of the assets. If the level of liabilities required is higher<br />

than total liabilities, then the deficiency should decrease the<br />

unrealized gains recorded in equity and increase liabilities<br />

through a shadow premium deficiency adjustment.<br />

This requires the liability adequacy test (see Liability Adequacy<br />

Test) to be performed after all shadow adjustments - if any.<br />

Should there be insufficient unrealized capital gains left in<br />

equity to ac<strong>com</strong>modate the shadow loss adjustment, the<br />

additional liability increase should be charged to in<strong>com</strong>e<br />

(P/L).<br />

Discretionary participation feature (DPF)<br />

Discretionary participation feature is a contractual right to<br />

receive, as a supplement to guaranteed benefits, additional<br />

benefits:<br />

• that are likely to be a significant portion of the total contractual<br />

benefits;<br />

• whose amount or timing is contractually at the discretion<br />

of the issuer; and<br />

• that are contractually based on:<br />

• the performance of a specified pool of contracts or a specified<br />

type of contract;<br />

• realized and/or unrealized investment returns on a specified<br />

pool of assets held by the issuer; or<br />

• the profit or loss of the <strong>com</strong>pany, fund or other entity that<br />

issues the contract.<br />

All unrealized gains and losses <strong>com</strong>ing from investments<br />

backing insurance contracts and investment contracts with<br />

DPF are categorized proportionally for the part related to the<br />

insurance contracts and investment contracts with discretionary<br />

participation features in a separate line of the equity.<br />

Proportional calculation happens on the basis of the carried<br />

reserves and by separated management of the assets.<br />

Insurance contracts with deposit <strong>com</strong>ponent<br />

(unbundling)<br />

All unit-linked products that contain both an insurance contract<br />

and a deposit <strong>com</strong>ponent will be unbundled. Accounting<br />

policies for insurance contracts are applied for the insurance<br />

<strong>com</strong>ponent; accounting policies for financial instruments are<br />

applied for the deposit <strong>com</strong>ponent.<br />

The unit-linked products that can be converted into a guaranteed<br />

investment product (branch 21) with profit sharing<br />

fall under IFRS 4 (investment with DPF) and will not be<br />

unbundled.<br />

Embedded derivatives<br />

IAS 39 applies to derivatives embedded in an insurance contract<br />

unless the embedded derivative is itself an insurance<br />

contract. The requirements for insurance contracts with DPF<br />

also prevail for financial instruments with DPF elements.<br />

As an exception to the requirement in IAS 39, an insurer need<br />

not separate, and measure at fair value, a policyholder’s option<br />

to surrender an insurance contract for a fixed amount (or for<br />

an amount based on a fixed amount and an interest rate),<br />

even if the exercise price differs from the carrying amount<br />

of the host insurance liability. However, the requirement in<br />

IAS 39 does apply to a put option or cash surrender option<br />

embedded in an insurance contract if the surrender value varies<br />

in response to the change in a financial variable (such as<br />

an equity or <strong>com</strong>modity price or index), or a non-financial<br />

variable that is not specific to a party to the contract.<br />

DPF in financial instruments<br />

If the issuer classifies part or that entire feature as a separate<br />

<strong>com</strong>ponent of equity, the liability recognized for the whole<br />

contract shall not be less than the amount that would result<br />

from applying IAS 39 to the guaranteed element.<br />

<strong>Dexia</strong> reviews at each <strong>report</strong>ing date whether this minimum<br />

requirement is met and in case of an insufficiency, the corresponding<br />

liabilities are adjusted accordingly.<br />

Liability Adequacy Tests<br />

An insurer applies a liability adequacy test (LAT) for its insurance<br />

products and investment contracts with DPF. <strong>Dexia</strong><br />

assesses at each <strong>report</strong>ing date whether its recognized insurance<br />

liabilities are adequate, using current estimates of future<br />

cash flows under its insurance contracts.<br />

If that assessment (based on the entire life and nonlife insurance<br />

portfolios separately) shows that the carrying amount of<br />

its insurance liabilities (less related deferred acquisition costs<br />

and related intangible assets) is inadequate in the light of the<br />

estimated future cash flows, the entire deficiency shall be recognized<br />

in profit or loss.<br />

For life insurance, LAT uses the following parameters, which<br />

are based on the Royal Decree of November 14, 2003 with<br />

respect to the life business :<br />

• premiums: collected inventory premiums plus contractual<br />

provided inventory premiums;<br />

• interest rate for actualization cash flows: yields of the assets<br />

backing insurance liabilities;<br />

• mortality table: experience table of the country (Assuralia<br />

for Belgium);<br />

• costs : calculation based on the last updated tariff costs and<br />

the booked costs;<br />

• tariff costs take into account the inventory surcharges, <strong>com</strong>mercial<br />

surcharges and fixed sums;<br />

• real assigned costs take into account management<br />

expenses, claims handling expenses and <strong>com</strong>missions. These<br />

costs are stipulated by product group and are indexed. Considering<br />

lapses, death and expiration period the annual delta<br />

is stipulated between the costs in the tariff and real assigned<br />

costs. Deltas are then actualised to the LAT-rate.<br />

For nonlife insurance, the LAT that examines if the premium<br />

and claim provisions are sufficient to settle definitely the<br />

opened claim files and the claims that will occur within the<br />

contractual duration of the contracts to open and to settle<br />

definitively.<br />

A LAT is carried out for all products. The test is subdivided into<br />

two parts. During the first part <strong>Dexia</strong> examines if the build up<br />

reserves for claim files already opened are sufficient, and in a<br />

second part <strong>Dexia</strong> makes an estimation of the expected loss<br />

burden for insurance portfolios and examine if the unearned<br />

premium reserves are sufficient.<br />

124 |<br />

<strong>Dexia</strong> / <strong>Annual</strong> Report <strong>2006</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!